EIP ECZACIBAS ILAC PAZARLAMA A.S.

Company Introduction:

Eczacıbaşı İlaç Pazarlama A.Ş. is a leading Turkish company operating within the pharmaceutical sector. It functions as a key subsidiary of the Eczacıbaşı Group, a diversified industrial conglomerate with significant interests across various sectors including healthcare, consumer products, and building materials. This particular entity specializes in the marketing, sales, and distribution of a comprehensive portfolio of pharmaceutical products throughout Turkey. It plays a vital role in ensuring that medicines reach pharmacies, hospitals, and ultimately patients, leveraging an extensive distribution network and a dedicated sales team. The company is committed to improving public health by providing high-quality pharmaceutical solutions and fostering strong relationships within the healthcare community.

Factory or Trader:

Eczacıbaşı İlaç Pazarlama A.Ş. is primarily a trader and distributor. It focuses on the marketing, sales, and logistics of pharmaceutical products rather than manufacturing them directly. While the broader Eczacıbaşı Group does encompass pharmaceutical manufacturing facilities, Eczacıbaşı İlaç Pazarlama A.Ş. operates specifically as the commercial and distribution arm.

Eczacibasi Ilac Pazarlama A.S. in Turkey markets and sells a broad portfolio of pharmaceutical and healthcare products. These products primarily encompass prescription drugs covering various therapeutic areas such as cardiovascular system conditions, central nervous system disorders, gastrointestinal issues, metabolic and endocrine system treatments, anti-infectives, respiratory system medications, urogenital system drugs, musculoskeletal remedies, oncology treatments, and dermatological products. Additionally, the company distributes over-the-counter (OTC) products for general health and common ailments, as well as dermocosmetics and specialized skincare items. These products are often manufactured by Eczacibasi Ilac Sanayi and other companies within the Eczacibasi Group, including those from international collaborations.